Tobrex · DIN 00513962 · 0.3% · Oph Sol
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Tobrex · DIN 00513962
Manufacturer: Novartis Pharma Canada Inc.; listing date 1996-10-01
Health Canada: Marketed since 2018-09-10 · brand TOBREX · ATC S01AA12 TOBRAMYCIN · form Solution · route Ophthalmic · ingredients TOBRAMYCIN 0.3 %/W/V · company Novartis pharmaceuticals canada inc · schedule Prescription
Ministry pays: $1.3620 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00513962)
Source record
DIN 00513962: Tobrex
Raw flags: sec3=Y
Item: 520404020; group id 584; item number 1540; lccId None; manufacturer id NOV
Source form: Oph Sol; strength: 0.3%
Recorded listing: General benefit
Source prices (unrounded): $1.9400; ministry $1.3620
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00513962
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=4571
Interchangeable products
Sandoz Tobramycin · DIN 02241755 · $1.3620
Shortage status: resolved shortage (ended February 4, 2019); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00513962
Shortage record checked October 6, 2026